486 related articles for article (PubMed ID: 18206512)
41. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
42. [Advice and handy drugs can be sufficient in bee and wasp venom allergy].
Foucard T
Lakartidningen; 1991 Jun; 88(26-27):2365-6. PubMed ID: 1857153
[No Abstract] [Full Text] [Related]
43. [Evolution of in vivo and in vitro tests during specific immunotherapy against hymenoptera venoms].
Sabbah A; Heulin MG; Soulière I
Allerg Immunol (Paris); 1990 Jun; 22(6):242-7. PubMed ID: 1696102
[TBL] [Abstract][Full Text] [Related]
44. Severe anaphylaxis to hymenoptera stings: does the basal serum tryptase concentration really matter?
Seidel S; Voller B; Geusau A; Wöhrl S
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):185-7. PubMed ID: 20674833
[No Abstract] [Full Text] [Related]
45. Higher frequency of early local side effects with aqueous versus depot immunotherapy for hymenoptera venom allergy.
Cadario G; Marengo F; Ranghino E; Rossi R; Gatti B; Cantone R; Bona F; Pellegrino R; Feyles G; Puccinelli P; Burastero SE
J Investig Allergol Clin Immunol; 2004; 14(2):127-33. PubMed ID: 15301302
[TBL] [Abstract][Full Text] [Related]
46. Stinging Hymenoptera and mastocytosis.
Ruëff F; Dugas-Breit S; Przybilla B
Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
[TBL] [Abstract][Full Text] [Related]
47. Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy.
Bidad K; Nawijn MC; van Oosterhout AJ; van der Heide S; Elberink JN
Cytometry B Clin Cytom; 2014 May; 86(3):183-90. PubMed ID: 24478037
[TBL] [Abstract][Full Text] [Related]
48. Answer to the letter of Brockow et al. concerning our article 'safety of rush insect venom immunotherapy. Results of a retrospective study in 178 patients'.
Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
Allergy; 2005 Jan; 60(1):127. PubMed ID: 15575945
[No Abstract] [Full Text] [Related]
49. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients.
Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
Allergy; 2003 Nov; 58(11):1176-9. PubMed ID: 14616130
[TBL] [Abstract][Full Text] [Related]
50. [Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study].
Tworek D; Bocheńska-Marciniak M; Kupczyk M; Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2006; 74(2):153-8. PubMed ID: 17269362
[TBL] [Abstract][Full Text] [Related]
51. [Allergy to bee and yellow jacket venoms].
Saari S; Kalimo K; Viander M; Henriksson S
Duodecim; 1985; 101(4):393-401. PubMed ID: 3979324
[No Abstract] [Full Text] [Related]
52. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
[TBL] [Abstract][Full Text] [Related]
53. [Immunotherapy of hymenoptera allergy].
Hirata H; Fukuda T
Arerugi; 2008 May; 57(5):491-8. PubMed ID: 18520168
[No Abstract] [Full Text] [Related]
54. CD30 serum levels and response to hymenoptera venom immunotherapy.
Foschi FG; Emiliani F; Savini S; Quercia O; Stefanini GF
J Investig Allergol Clin Immunol; 2008; 18(4):279-83. PubMed ID: 18714536
[TBL] [Abstract][Full Text] [Related]
55. [Hypersensitivity reactions caused by insect stings].
van der Zwan JC; de Monchy JG; de Vries K
Ned Tijdschr Geneeskd; 1980 May; 124(21):833-7. PubMed ID: 7383202
[No Abstract] [Full Text] [Related]
56. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
57. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
Müller UR; Golden DB; Demarco PJ; Lockey RF
Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
[No Abstract] [Full Text] [Related]
58. Comparison of Swedish and Japanese venom antigens in the diagnosis of Hymenoptera hypersensitivity in Japan.
Namai S; Ikemori R; Makino S
Asian Pac J Allergy Immunol; 1983 Dec; 1(2):143-8. PubMed ID: 6681006
[No Abstract] [Full Text] [Related]
59. [Natural history of allergic reactions to Hymenoptera insect bites].
Brewczyński PZ; Spiewak R; Klin MJ
Pol Tyg Lek; 1994 Apr 4-11; 49(14-15):330-3. PubMed ID: 7854993
[TBL] [Abstract][Full Text] [Related]
60. Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway.
Gangemi S; Patella V; Cianci E; Saitta S; Lattanzio S; Florio G; Romano M
Ann Allergy Asthma Immunol; 2012 Sep; 109(3):226-7. PubMed ID: 22920084
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
